Skip to main content
. 2024 Feb 19;14(1):31. doi: 10.1038/s41408-024-00990-3

Fig. 4. Cumulative incidence of GVHD.

Fig. 4

aGVHD grade II-IV(A), aGVHD grade III-IV(B), cGVHD (C), cGVHD requiring systemic treatment (D) according to the use of post-transplant cyclophosphamide (PTCy) or anti-thymocyte globulin (ATG).